United Parcel Service (UPS): Before Open
Basic Information:
Market Cap: $155.89B
Current Price: $181.50
52-Week Range: $154.87 - $209.39
Dividend: $6.48 (Dividend Yield: 3.58%)
Earnings and Valuation:
P/E Ratio: 14.62, indicating the stock is trading at a relatively moderate valuation based on earnings.
Forward P/E Ratio: 15.43, showing a slightly higher valuation based on expected future earnings.
P/FCF Ratio: 79.01, suggesting the stock is trading at a high multiple of its free cash flow.
P/B Ratio: 7.78, indicating the stock is trading at a premium compared to its book value.
P/S Ratio: 1.58, suggesting investors are paying $1.58 for every dollar of revenue generated by the company.
Earnings and Revenue:
EPS (ttm): $12.37, showing the company's earnings over the trailing twelve months.
EPS Next Year: $11.73, indicating a slight decline in earnings expected for the next fiscal year.
EPS Next 5 Years: -0.33%, suggesting a relatively flat earnings growth projection over the next five years.
EPS Q/Q: -27.70%, indicating a significant decline in earnings compared to the same quarter in the previous year.
Sales: $98.89B, with a negative sales growth of -6.00% quarter over quarter.
Profitability and Management:
Profit Margin: 10.90%, showing a decent level of profitability.
ROA (Return on Assets): 15.20%, indicating the company's efficiency in utilizing its assets to generate profit.
ROE (Return on Equity): 59.00%, representing a strong return on shareholders' equity.
Technical Indicators:
RSI (14): 45.57, suggesting the stock is currently neutral with a slight bearish bias.
Beta: 1.08, indicating the stock's price movement is moderately correlated with the market.
Analyst Opinions:
Recommendation (Recom): 2.40, indicating a Buy to Hold recommendation from analysts.
Target Price: $190.89, which suggests a potential upside from the current price.
Detailed Technical Analysis: The stock's 20-day Simple Moving Average (SMA20) is -2.20%, indicating a short-term downward trend. The 50-day SMA (SMA50) is 1.72%, suggesting a slight upward trend, and the 200-day SMA (SMA200) is 0.80%, indicating a relatively stable long-term trend.
Detailed Fundamental Analysis: The company has seen a negative sales growth over the past five years at 8.50%, but the profit margin is at a decent level of 10.90%. The return on equity (ROE) is strong at 59.00%, indicating effective management in generating returns for shareholders.
Detailed Outlook: United Parcel Service (UPS) is a global package delivery and supply chain management company. The company has been facing challenges due to fluctuations in shipping demand and increased competition. The negative Q/Q earnings growth suggests the impact of these challenges on the company's performance.
Prediction of Earnings: Based on the consensus EPS estimate of $2.51, if the actual earnings are in line with or higher than $2.51, it would be considered a "meet" or "beat" on earnings. If the actual earnings are below $2.51, it would be considered a "miss" on earnings. Please note that stock analysis involves various factors, and this information provides a snapshot of the stock's current situation.
AMC (AMC): After Hours
Basic Information:
Market Cap: $2.55B
Current Price: $4.91
52-Week Range: $3.77 - $16.89
Dividend: No dividend is issued by the company.
Earnings and Valuation:
P/E Ratio: Not available due to negative trailing twelve months (ttm) earnings (-1.40).
Forward P/E Ratio: Not available as no consensus EPS estimate is provided for the next year.
PEG Ratio: Not applicable due to negative earnings.
P/S Ratio: 0.62, indicating the stock is trading at 0.62 times its sales per share.
P/B Ratio: Not available as no book value is provided.
Earnings and Revenue:
EPS (ttm): -$1.40, meaning the company has negative earnings per share over the trailing twelve months.
EPS Next Year: -$0.23, showing an improvement in earnings expected for the next fiscal year.
EPS Next 5 Years: Not available due to missing data.
EPS Q/Q: 73.80%, indicating a significant increase in earnings compared to the same quarter in the previous year.
Sales: $4.08B, with a robust sales growth of 21.50% quarter over quarter.
Profitability and Management:
Profit Margin: -21.40%, indicating the company is operating at a loss.
ROA (Return on Assets): -9.40%, suggesting the company's inefficiency in using its assets to generate profit.
ROE (Return on Equity): 34.50%, showing a positive return on shareholders' equity.
Stock Performance:
Performance Year-to-Date: 21.13%, indicating a moderate increase in the stock price since the beginning of the year.
Performance Quarter: -16.72%, suggesting a decline in the stock price over the past three months.
Performance Half-Year: -18.91%, showing a decrease in the stock price over the last six months.
Technical Indicators:
RSI (14): 54.64, indicating the stock is neither overbought nor oversold.
Beta: 1.82, suggesting the stock is more volatile than the market.
Analyst Opinions:
Recommendation (Recom): 3.90, suggesting a Hold to Buy recommendation from analysts.
Target Price: $2.27, which implies potential downside from the current price.
Upcoming Earnings:
Earnings Date: August 8, after the market close.
Prediction of Hitting, Missing, or Beating Earnings: Based on the provided data and the recent positive sales growth, there might be a possibility of improved earnings compared to the previous year's quarter (73.80% increase Q/Q). However, keep in mind that historical performance may not always be indicative of future results, and earnings can be impacted by various factors such as business operations, industry trends, and market conditions.
Data Dog (DDOG): Before Market Open
Basic Information:
Market Cap: $24.89B
Current Price: $26.50
52-Week Range: $11.68 - $40.86
Dividend: The company does not issue dividends.
Earnings and Valuation:
P/E Ratio: Not applicable (-) due to negative earnings.
Forward P/E Ratio: Not available.
PEG Ratio: Not applicable (-) due to negative earnings.
P/S Ratio: 11.19, indicating investors are paying $11.19 for every dollar of revenue the company generates.
P/B Ratio: 1.84, suggesting the stock is trading at a reasonable premium compared to its book value.
Earnings and Revenue:
EPS (ttm): -$7.08, indicating the company has negative earnings per share over the trailing twelve months.
EPS Next Year: -$3.37, showing a negative growth expectation for the next fiscal year.
EPS Next 5 Years: Not available.
EPS Q/Q: 18.00%, indicating a positive growth in earnings compared to the same quarter in the previous year.
Sales: $2.22B, with a significant sales growth of 595.80% quarter over quarter.
Profitability and Management:
Profit Margin: Not available.
ROA (Return on Assets): -34.60%, suggesting the company is not efficiently using its assets to generate profit.
ROE (Return on Equity): -44.30%, indicating a negative return on shareholders' equity.
Technical Indicators:
RSI (14): 56.60, suggesting the stock is neither overbought nor oversold.
Stock Performance:
Performance Year-to-Date: 37.06%, indicating a positive price movement since the beginning of the year.
Performance Quarter: 95.06%, showing strong performance over the past three months.
Performance Half-Year: 20.98%, indicating moderate growth over the last six months.
Analyst Opinions:
Recommendation (Recom): 2.30, suggesting a moderate Buy recommendation from analysts.
Target Price: $25.95, which suggests potential downside from the current price.
Detailed Technical Analysis: The stock's price has been volatile with a 52-week range of $11.68 to $40.86. The stock is currently trading at $26.50, below its 52-week high. The RSI (14) is 56.60, indicating a neutral position for the stock.
Detailed Fundamental Analysis: RIVN is a high-growth company with a substantial increase in sales and a significant negative EPS. The company has negative ROA and ROE, indicating operational inefficiencies and financial challenges. The lack of dividends and positive PEG ratio further suggests that the stock may not be attractive for value investors.
Detailed Outlook: The outlook for RIVN is subject to various factors, including the company's ability to increase revenue and improve operational efficiency. As an electric vehicle manufacturer, RIVN is in a competitive industry with potential for growth. However, it is essential to closely monitor the company's financials and developments in the electric vehicle market.
Prediction of Earnings: Given the negative EPS and the lack of consensus EPS provided, it is challenging to predict whether RIVN will meet, beat, or miss earnings expectations. Analysts may have varying opinions, and market sentiment could impact the stock's performance following the earnings release.
Basic Information:
Market Cap: $34.47B
Current Price: $107.10
52-Week Range: $61.34 - $120.75
Dividend: No dividend is issued by the company.
Earnings and Valuation:
P/E Ratio: Not applicable (-) due to negative earnings.
Forward P/E Ratio: 69.42, which indicates that the stock is relatively expensive based on expected future earnings.
PEG Ratio: Not applicable (-) due to negative earnings.
P/S Ratio: 19.22, which implies that investors are paying $19.22 for every dollar of revenue the company generates.
P/B Ratio: 22.69, indicating the stock is trading at a significant premium compared to its book value.
P/FCF Ratio: 101.42, suggesting the stock is relatively expensive based on its free cash flow.
Earnings and Revenue:
EPS (ttm): -$0.27, which means the company has negative earnings per share over the trailing twelve months.
EPS Next Year: $1.55, showing a positive growth expectation for the next fiscal year.
EPS Next 5 Years: 22.65%, pointing to a strong growth projection over the next five years.
EPS Q/Q: -402.90%, indicating a significant decline in earnings compared to the same quarter in the previous year.
Sales: $1.79B, with robust sales growth of 32.70% quarter over quarter.
Profitability and Management:
Profit Margin: -4.70%, indicating the company is currently operating at a loss.
ROA (Return on Assets): -2.90%, showing the company's inefficiency in using its assets to generate profit.
ROE (Return on Equity): -6.20%, representing a negative return on shareholders' equity.
Stock Performance:
Performance Year-to-Date: 46.30%, suggesting a considerable increase in the stock price since the beginning of the year.
Performance Quarter: 42.61%, indicating a strong performance over the past three months.
Performance Half-Year: 23.64%, showing significant growth over the last six months.
Technical Indicators:
RSI (14): 50.92, which implies the stock is neither overbought nor oversold.
Beta: 0.96, indicating the stock is relatively less volatile than the market.
Detailed Outlook: Based on the provided data, Datadog Inc. has been experiencing strong sales growth, but its profitability remains a concern, with negative margins and earnings. The forward P/E ratio indicates investors have high expectations for future earnings, and the P/B and P/FCF ratios suggest the stock is trading at a premium compared to its book value and free cash flow.
The stock has shown positive momentum in the short term, with gains in the quarter and year-to-date, and has outperformed the market significantly. However, it is currently facing resistance near its 52-week high.
Prediction of Hitting, Missing, or Beating Earnings: Based on the negative EPS and past quarter's negative EPS growth, it is challenging to predict with certainty. However, given the strong sales growth and the positive outlook for the next fiscal year, there is a possibility that Datadog might beat earnings expectations. Investors should closely monitor the company's earnings report and other market developments to assess its performance accurately.
Upstart Holdings (UPST): After Close
1. Basic Information:
Market Cap: $5.64B
Current Price: $68.21
52-Week Range: $11.93 - $72.58
Dividend: No dividend is issued by the company.
2. Earnings and Valuation:
P/E Ratio: Not applicable (-) due to negative earnings.
Forward P/E Ratio: 93.86, which indicates that the stock is relatively expensive based on expected future earnings.
PEG Ratio: Not applicable (-) due to negative earnings.
P/S Ratio: 7.94, which implies that investors are paying $7.94 for every dollar of revenue the company generates.
P/B Ratio: 7.93, indicating the stock is trading at a premium compared to its book value.
3. Earnings and Revenue:
EPS (ttm): -$3.30, which means the company has negative earnings per share over the trailing twelve months.
EPS Next Year: $0.65, showing a significant positive growth expectation for the next fiscal year.
EPS Next 5 Years: 30.00%, indicating a relatively moderate growth projection over the next five years.
EPS Q/Q: -560.70%, indicating a substantial decline in earnings compared to the same quarter in the previous year.
Sales: $710.40M, with a significant sales decline of 62.70% quarter over quarter.
4. Profitability and Management:
Profit Margin: -38.10%, indicating the company is currently operating at a loss.
ROA (Return on Assets): -14.30%, showing the company's inefficiency in using its assets to generate profit.
ROE (Return on Equity): -39.00%, representing a negative return on shareholders' equity.
5. Stock Performance:
Performance Year-to-Date: 359.34%, indicating a significant increase in the stock price since the beginning of the year.
Performance Quarter: 387.36%, indicating an outstanding performance over the past three months.
Performance Half-Year: 154.61%, showing substantial growth over the last six months.
6. Technical Indicators:
RSI (14): 58.16, which implies the stock is neither overbought nor oversold.
Beta: 1.83, indicating the stock is more volatile than the market.
7. Analyst Opinions:
Recommendation (Recom): 3.70, indicating a Hold to Buy recommendation from analysts.
Target Price: $22.93, which suggests potential downside from the current price.
8. Other Information:
Short Interest: 25.86M shares are sold short, indicating some investors are betting on a decline in the stock price.
Insider Ownership: 1.70%, suggesting limited insider interest in the company.
Institutional Ownership: 39.40%, indicating moderate institutional interest.
Detailed Technical Analysis:
The stock's RSI (Relative Strength Index) of 58.16 suggests it is currently in a neutral state and not heavily overbought or oversold.
The stock's SMA20 (Simple Moving Average 20) and SMA50 (Simple Moving Average 50) indicate positive trends in the short and medium term, respectively.
The stock's SMA200 (Simple Moving Average 200) indicates a strong upward trend in the long term.
Detailed Fundamental Analysis:
The company has negative earnings and has been experiencing a decline in sales over the past year.
The stock has shown significant volatility, with substantial gains and losses in short periods.
Upstart has a moderate level of institutional ownership, indicating some interest from larger investors.
The company's P/S ratio suggests a relatively high valuation compared to its revenue.
Detailed Outlook:
The stock has performed exceptionally well over the past year, showing substantial growth.
The company's fundamental metrics, such as negative earnings and declining sales, may pose risks to the stock's performance.
The future growth projection is positive, which could be a factor in driving the stock price.
Short interest in the stock indicates that some investors are bearish on the company's prospects.
Prediction of Hitting, Missing, or Beating Earnings: Based on the consensus EPS of ($0.49) and the company's historical earnings performance, it is challenging to make a precise prediction. The stock's performance may depend on various factors, including market sentiment, the company's actual earnings performance, and future guidance provided by the management during the earnings call.
Twilio Inc. (TWLO): After Close
Basic Information:
Market Cap: $11.37B
Current Price: $61.28
52-Week Range: $41.00 - $98.67
Dividend: No dividend is issued by the company.
Detailed Technical Analysis:
RSI (14): 44.84, indicating the stock is neither overbought nor oversold.
Beta: 1.34, suggesting the stock is moderately more volatile than the market.
SMA20: -4.28%, showing a negative trend over the past 20 days.
SMA50: -4.77%, indicating a negative trend over the past 50 days.
SMA200: 3.64%, suggesting a positive trend over the past 200 days.
Volatility: 3.67% (short-term) / 4.61% (long-term), indicating moderate stock price fluctuations.
Detailed Fundamental Analysis:
EPS (ttm): -$7.47, which means the company has negative earnings over the trailing twelve months.
EPS Next Year: $1.86, showing a positive growth expectation for the next fiscal year.
EPS Next 5 Years: Not available (-) due to negative earnings.
EPS Q/Q: -49.80%, indicating a decline in earnings compared to the same quarter in the previous year.
Sales: $3.96B, with a solid sales growth of 15.00% quarter over quarter.
Profit Margin: -34.80%, indicating the company is currently operating at a loss.
ROA (Return on Assets): -10.90%, showing the company's inefficiency in using its assets to generate profit.
ROE (Return on Equity): -13.00%, representing a negative return on shareholders' equity.
Debt/Equity: 0.10, indicating a relatively low level of debt compared to equity.
Gross Margin: 47.50%, representing the percentage of revenue that exceeds the cost of goods sold.
Operating Margin: -32.80%, indicating the company's operating inefficiency.
Quick Ratio: 6.20, suggesting the company has sufficient liquid assets to cover short-term obligations.
Current Ratio: 6.20, showing a good ability to meet short-term obligations.
Detailed Outlook: Twilio is a cloud communications platform that enables developers to build, scale, and operate real-time communications within software applications. The company's services are essential for businesses and developers to communicate effectively with their customers. Twilio has been experiencing solid revenue growth in recent years due to the increasing adoption of cloud-based communication solutions. However, the company is currently operating at a loss, and its negative EPS raises concerns about its profitability.
Prediction of Hitting, Missing, or Beating Earnings: Considering the negative EPS consensus of ($0.47) and the company's historical performance, there is a possibility that Twilio may miss earnings expectations.
The decline in earnings year-over-year and quarter-over-quarter indicates some challenges the company may be facing. However, it's important to note that stock prices can be influenced by various factors, and earnings predictions involve uncertainties.
Marathon Holdings (MARA): After Close
Basic Information:
Market Cap: $2.69B
Current Price: $16.56
52-Week Range: $3.11 - $19.88
Dividend: No dividend is issued by the company.
Detailed Technical Analysis:
RSI (14): 50.44, indicating the stock is trading around the neutral zone.
SMA20: -6.65%, showing a recent decline in the stock price.
SMA50: 17.84%, indicating a positive trend over the past 50 days.
SMA200: 70.48%, suggesting a strong upward trend over the past 200 days.
Volatility: 6.75% (short-term) and 7.83% (long-term), which indicates moderate volatility in the stock price.
Detailed Fundamental Analysis:
P/E Ratio: Not applicable (-) due to negative earnings.
P/FCF (Price to Free Cash Flow): Not available as free cash flow information is missing.
P/B Ratio (Price to Book Ratio): 4.62, suggesting the stock is trading at a premium compared to its book value.
P/S Ratio (Price to Sales Ratio): 22.96, indicating investors are paying $22.96 for every dollar of revenue generated by the company.
PEG Ratio (Price/Earnings to Growth Ratio): Not available as the P/E is not applicable.
ROE (Return on Equity): -122.90%, indicating negative profitability relative to shareholders' equity.
ROA (Return on Assets): -49.70%, showing the company's inefficiency in using its assets to generate profit.
Detailed Outlook:
MARA has shown substantial growth over the past year, with a YTD performance of 362.87%.
The company's recent earnings report indicated a positive EPS growth of 63.50% year over year.
The stock is currently trading near its 52-week high, which might indicate a potential resistance level.
The high beta of 5.08 suggests that the stock is significantly more volatile than the overall market.
The short float of 26.18% implies that some investors are betting on a decline in the stock price.
Prediction of Hitting, Missing, or Beating Earnings: Based on the consensus EPS of ($0.03) and the recent positive EPS growth trend, there is a possibility that MARA could potentially beat earnings expectations. However, it's important to note that earnings predictions can be unpredictable, and various other factors can influence the stock's performance following the earnings release.
Eli Lilly and Company (LLY): Before Market Open
Basic Information:
Market Cap: $426.38B
Current Price: $449.49
52-Week Range: $296.32 - $469.87
Dividend: $4.52 (Dividend Yield: 1.01%)
Earnings and Valuation:
P/E Ratio: 71.36, indicating investors are paying $71.36 for every dollar of earnings.
Forward P/E Ratio: 36.60, suggesting a more moderate valuation based on expected future earnings.
P/FCF (Price to Free Cash Flow): 3613.37, reflecting a very high valuation concerning free cash flow.
P/B Ratio: 36.19, indicating the stock is trading at a significant premium compared to its book value.
P/S Ratio: 15.40, implying investors are paying $15.40 for every dollar of revenue the company generates.
PEG Ratio: 2.97, suggesting the stock is relatively expensive considering the company's earnings growth rate.
Profitability and Management:
ROE (Return on Equity): 56.20%, indicating the company is efficient in generating returns for its shareholders.
ROA (Return on Assets): 11.50%, showing the company's efficiency in using its assets to generate profit.
Profit Margin: 20.50%, representing the percentage of revenue that translates into profit.
Technical Indicators:
RSI (14): 47.21, suggesting the stock is neither overbought nor oversold.
SMA20: -0.58%, indicating a slight decline in the stock's price compared to the 20-day simple moving average.
SMA50: 0.08%, showing a marginal increase in the stock's price compared to the 50-day simple moving average.
SMA200: 17.67%, indicating a significant increase in the stock's price compared to the 200-day simple moving average.
Earnings and Revenue:
EPS (ttm): $6.30, representing the company's earnings per share over the trailing twelve months.
EPS Next Year: $12.28, suggesting a significant growth expectation for the next fiscal year.
EPS Q/Q: -29.10%, indicating a decline in earnings compared to the same quarter in the previous year.
Sales: $27.69B, with a decline of 10.90% quarter over quarter.
Outlook: Eli Lilly and Company is a large pharmaceutical company with a strong presence in the healthcare industry. The stock has shown positive performance over the year, with a notable increase in the share price. The company's profitability metrics, including ROE and ROA, indicate efficient management and the ability to generate returns for shareholders.
However, the recent decline in EPS and sales may raise concerns about the company's performance. Investors should closely monitor the upcoming earnings report on August 8 (BMO) to gain insights into the company's financial health and future prospects.
Prediction of Earnings: Given the recent decline in EPS and sales, there might be a possibility of the company missing earnings expectations. However, the final outcome will depend on various factors, including company performance and market conditions. Please note that predictions are speculative, and actual results may vary.
Vital Energy (VTLE): After Close
Basic Information:
Market Cap: $979.52M
Current Price: $52.66
52-Week Range: $39.74 - $83.22
Dividend: No dividend is issued by the company.
Fundamental Analysis:
P/E Ratio: 1.08, which indicates the stock is trading at a relatively low multiple of its earnings.
Forward P/E Ratio: 2.78, suggesting the stock is expected to remain cheap based on future earnings estimates.
PEG Ratio: 0.10, implying that the stock is undervalued relative to its expected earnings growth rate.
P/S Ratio: 0.57, which indicates that investors are paying $0.57 for every dollar of revenue the company generates.
P/B Ratio: 0.72, suggesting the stock is trading at a reasonable price compared to its book value.
P/FCF (Price/Free Cash Flow) Ratio: 5.70, showing that the stock's price is relatively high compared to its free cash flow.
Profitability and Management:
ROE (Return on Equity): 82.90%, indicating the company is efficient in using shareholder equity to generate profit.
ROA (Return on Assets): 29.30%, showing the company's effectiveness in utilizing its assets to generate profit.
Profit Margin: 48.40%, indicating the company has a healthy profit margin.
Earnings and Revenue:
EPS (ttm): $49.51, indicating high earnings per share over the trailing twelve months.
EPS Next Year: 19.20%, representing a positive growth expectation for the next fiscal year.
EPS Q/Q: 233.10%, indicating a significant improvement in earnings compared to the same quarter in the previous year.
Sales: $1.72B, with a decline of 37.50% quarter over quarter.
Technical Indicators:
RSI (14): 64.53, suggesting the stock is moderately overbought.
SMA20: 7.77%, indicating a positive trend over the last 20 days.
SMA50: 16.18%, showing a positive trend over the last 50 days.
SMA200: 4.72%, indicating a positive long-term trend over the last 200 days.
Outlook: The company's earnings have shown substantial growth, and its profitability metrics (ROE, ROA, and profit margin) are impressive. However, the decline in sales over the past quarter is a concern. The stock has been relatively volatile, with a wide 52-week range.
Prediction for Earnings: Based on the information provided, it's difficult to make a precise prediction on whether VTLE will meet, beat, or miss on earnings. The stock's fundamental metrics look promising, and earnings growth has been strong. However, the recent decline in sales could impact earnings for the upcoming quarter. Investors should closely monitor the company's earnings report to get a clearer picture of its financial performance. Zoetis Inc. (ZTS): Before Market Open
Basic Information:
Market Cap: $83.59B
Current Price: $180.88
52-Week Range: $124.15 - $194.99
Dividend: $1.50 (Dividend Yield: 0.84%)
Consensus EPS (Expected): $1.32
Fundamental Analysis:
P/E Ratio: 40.34, indicating that the stock is trading at a relatively high multiple compared to its earnings.
P/FCF (Price/Free Cash Flow): 101.07, implying the stock's price is expensive relative to its free cash flow.
P/B (Price/Book Ratio): 18.42, suggesting the stock is trading at a significant premium to its book value.
ROE (Return on Equity): 45.70%, showing that the company generates a strong return on shareholder equity.
PEG Ratio: 3.59, which suggests that the stock might be overvalued relative to its expected earnings growth.
Technical Analysis:
RSI (14): 49.88, indicating that the stock is currently neither overbought nor oversold.
SMA20 (Simple Moving Average - 20 days): -0.02%, suggesting a relatively flat trend over the short term.
SMA50 (Simple Moving Average - 50 days): 3.67%, showing a modest uptrend over the medium term.
SMA200 (Simple Moving Average - 200 days): 8.95%, indicating a positive long-term trend.
Detailed Outlook: Zoetis Inc. (ZTS) is a global animal health company that develops and manufactures vaccines, medicines, and diagnostic products for livestock and pets. The company has a strong presence in the animal health industry and benefits from a diverse portfolio of products. ZTS has shown steady revenue growth over the years, and its recent performance suggests resilience in challenging market conditions.
The COVID-19 pandemic has brought increased awareness of pet health and wellness, leading to an uptick in pet ownership. This trend has positively impacted ZTS's performance, particularly in its companion animal products segment. Additionally, the livestock industry's continued growth and focus on animal health and productivity have contributed to the company's revenue stream.
Prediction of Earnings Performance: Considering the company's historical performance and the current market conditions, there is a possibility that ZTS might meet or slightly beat the consensus EPS estimate of $1.32. The animal health industry's steady growth and potential tailwinds from increased pet ownership during the pandemic could support the company's earnings.
Sunworks (SUNW): Before Market Open
Consensus EPS: ($0.16)
ROE: -40.40%
P/E: N/A (negative earnings)
P/FCF: N/A (negative earnings)
P/B: 0.85
Current Ratio: 1.40
P/S: 0.32
PEG: N/A (negative earnings)
RSI: 46.31
SMA20: -9.31%
SMA50: 2.84%
SMA200: -16.57%
Basic Information:
Market Cap: $53.49M
Current Price: $1.45
52-Week Range: $0.73 - $4.72
Dividend: No dividend is issued by the company.
Detailed Technical Analysis: SUNW's Relative Strength Index (RSI) is currently at 46.31, suggesting that the stock is neither overbought nor oversold. The stock price is currently below its 20-day simple moving average (SMA20), indicating a short-term bearish trend. However, it is above its 50-day (SMA50) and 200-day (SMA200) moving averages, which could be seen as bullish indicators.
Detailed Fundamental Analysis: SUNW has negative earnings per share (EPS) and, therefore, does not have a P/E ratio or PEG ratio. The P/B ratio is 0.85, indicating that the stock is trading slightly below its book value. The P/S ratio is 0.32, which means investors are paying $0.32 for every dollar of revenue the company generates. The company has a negative return on equity (ROE) and a negative return on assets (ROA), indicating that it is not efficiently utilizing its equity and assets to generate profit. SUNW has shown a positive EPS growth this year and over the past five years.
Detailed Outlook: SUNW is a relatively small company with a market capitalization of $53.49M. It operates with a positive sales growth of 21.50% quarter over quarter and has shown positive EPS growth over the past five years. However, it is currently operating at a loss, with a negative profit margin of -15.70% and an operating margin of -17.90%. The stock has been quite volatile, with a 52-week range from $0.73 to $4.72. It has experienced significant fluctuations in price, showing a 52-week low of $0.73 and a 52-week high of $4.72.
Prediction of Hitting, Missing, or Beating Earnings: Given the negative consensus EPS of ($0.16), it is likely that SUNW may miss earnings expectations. However, it's essential to consider that small-cap stocks like SUNW can be highly volatile, and earnings reports can lead to significant price movements. Investors should approach these predictions with caution and conduct further research before making any investment decisions.
Fate Therapeutics (FATE): After Close
Basic Information:
Market Cap: $363.00M
Current Price: $3.69
52-Week Range: $3.61 - $37.13
Dividend: No dividend is issued by the company.
Detailed Technical Analysis:
RSI (14): 26.95, indicating the stock is oversold and might be due for a potential rebound.
Beta: 1.42, suggesting the stock is more volatile than the market.
SMA20: -15.93%, showing a negative trend over the past 20 days.
SMA50: -23.85%, indicating a downward trend over the past 50 days.
SMA200: -58.15%, suggesting a long-term downward trend over the past 200 days.
Volatility: 5.16% (Daily), 4.50% (Weekly), indicating moderate fluctuations in the stock price.
Detailed Fundamental Analysis:
EPS (ttm): -$2.42, which means the company has negative earnings over the trailing twelve months.
EPS Next Year: -$2.00, suggesting a slight improvement in earnings expectations for the next fiscal year.
EPS Next 5 Years: Not available (-) due to missing data.
EPS Q/Q: 71.80%, indicating significant growth in earnings compared to the same quarter in the previous year.
Sales: $136.90M, showing substantial growth in sales of 220.70% quarter over quarter.
P/S Ratio: 2.65, which implies that investors are paying $2.65 for every dollar of revenue the company generates.
P/B Ratio: 0.77, indicating the stock is trading at a discount compared to its book value.
ROE (Return on Equity): -45.60%, representing a negative return on shareholders' equity.
ROA (Return on Assets): -32.50%, indicating the company's inefficiency in using its assets to generate profit.
Detailed Outlook: FATE appears to be facing significant challenges with its negative earnings, declining stock performance, and low profitability metrics. The company's stock price has experienced a substantial decline over the past year, and the recent earnings report will likely play a crucial role in determining its future trajectory.
Prediction of Hitting, Missing, or Beating Earnings: Based on the historical data of FATE's earnings and the consensus EPS estimate of ($0.58), it is challenging to provide an accurate prediction. However, it's worth noting that the company has a history of missing earnings expectations in the past. Given the negative earnings trend and recent decline in the stock price, there is a higher possibility that FATE might miss earnings expectations again. Investors should be cautious and closely monitor the earnings report on August 8th to assess the impact on the stock price.
Bluebird Bio Inc. (BLUE): Before Market Open
Consensus EPS: ($0.58)
ROE: -55.40%
P/B: 1.12
Current Ratio: 3.00
P/S: 101.90
RSI: 55.26
SMA20: 6.70%
SMA50: 8.73%
SMA200: -25.34%
Basic Information:
Market Cap: $407.59M
Current Price: $3.88
52-Week Range: $2.78 - $8.58
Dividend: No dividend is issued by the company.
Detailed Technical Analysis:
The stock has been showing positive momentum in the short term, as indicated by the rising SMA20 and SMA50. However, it has experienced significant losses in the long term, with the SMA200 indicating a downward trend. The stock's RSI of 55.26 suggests it is neither overbought nor oversold, indicating a balanced position
.
Detailed Fundamental Analysis:
The company has negative earnings per share (EPS) of -1.71 over the trailing twelve months (ttm). It is currently not profitable, as indicated by the negative profit margin and negative return on equity (ROE) of -21.00% and -55.40%, respectively. Additionally, the P/S ratio of 101.90 implies investors are paying a significant premium for every dollar of revenue generated by the company.
Detailed Outlook:
Bluebird Bio (BLUE) is a biotechnology company with a focus on gene therapies for severe genetic and rare diseases. The company has faced challenges in recent times, with losses in revenue and negative earnings. However, it has shown improvements in EPS this year, with a substantial increase of 58.50%. The sales growth of 26.30% Q/Q indicates some positive developments in the business.
The stock's price has experienced volatility, with a significant 52-week high of $8.58 and a 52-week low of $2.78. The stock has also seen considerable short interest, indicating a bearish sentiment among some investors.
Prediction of Hitting, Missing, or Beating Earnings:
Given the negative consensus EPS estimate of ($0.58), it is difficult to predict with certainty whether the company will beat or miss earnings. However, it's worth noting that the EPS this year has shown improvement, and the recent sales growth could potentially have a positive impact on earnings. Investors should closely monitor the company's earnings release on August 08 BMO to get a clearer picture of its financial performance.
TTWO (Take-Two Interactive): After Market Close
Consensus EPS: ($0.07)
ROE: -11.90%
P/B: 2.64
Current Ratio: 0.70
P/S: 4.63
RSI: 37.91
SMA20: -5.14%
SMA50: -0.98%
SMA200: 17.98%
Basic Information:
Market Cap: $24.75B
Current Price: $145.75
52-Week Range: $90.00 - $153.84
Dividend: No dividend is issued by the company.
Detailed Technical Analysis: The Relative Strength Index (RSI) is currently at 37.91, indicating that the stock is approaching oversold territory. The stock's volatility is relatively low, with a 2.01% volatility over 14 days.
Detailed Fundamental Analysis: TTWO's P/B ratio of 2.64 suggests that the stock is trading at a reasonable premium compared to its book value. The company's negative ROE of -11.90% reflects the inefficiency of generating profits from shareholders' equity. The P/S ratio of 4.63 indicates that investors are paying $4.63 for every dollar of revenue the company generates.
TTWO has seen a significant decrease in earnings over the past year, with a negative EPS this year and a negative EPS over the trailing twelve months. However, there is a positive growth expectation for the next fiscal year, with an EPS next year projected at 8.05%.
The company's financial performance in the past quarter has shown an improvement, with a positive EPS Q/Q of 481.90% and sales growth of 55.50% quarter over quarter. The net income remains negative, but the sales growth indicates some positive developments.
Detailed Outlook: Take-Two Interactive Software, Inc. (TTWO) is a leading video game publisher known for popular titles like Grand Theft Auto, NBA 2K, and Red Dead Redemption. The video game industry has experienced significant growth in recent years, driven by the rise of digital gaming and the ongoing demand for high-quality gaming experiences.
TTWO's financials show some mixed results, with negative earnings and profitability margins. However, the positive sales growth suggests the company is making strides in increasing its revenue.
The upcoming earnings release on August 8, AMC, will be a crucial event for investors to monitor. The market's reaction to the earnings report will depend on whether the company can demonstrate progress in its profitability and earnings. The gaming industry's competitive landscape is fierce, and TTWO's ability to continue releasing successful titles and monetizing its products will be critical to its future performance.
Prediction of Hitting, Missing, or Beating Earnings: Given the negative EPS consensus of ($0.07), it is challenging to predict with certainty whether TTWO will hit, miss, or beat earnings. The negative EPS suggests that the company may not have generated profits during the quarter. However, the positive sales growth and the upcoming release of highly anticipated game titles could impact the earnings report.
As an educational and entertainment exercise, let's consider that TTWO has a track record of surprise earnings. If the company manages to surprise the market positively with strong sales of its existing titles and provides optimistic guidance for future releases, it may have a chance to beat earnings expectations.
コメント